126 related articles for article (PubMed ID: 16520806)
1. Sustained remission from angioimmunoblastic T-cell lymphoma induced by alemtuzumab.
Halene S; Zieske A; Berliner N
Nat Clin Pract Oncol; 2006 Mar; 3(3):165-8; quiz 169. PubMed ID: 16520806
[TBL] [Abstract][Full Text] [Related]
2. Sustained, durable responses with alemtuzumab in refractory angioimmunoblastic T-cell lymphoma.
Amengual JE; Raphael BG
Leuk Lymphoma; 2010 Jul; 51(7):1347-50. PubMed ID: 20572801
[No Abstract] [Full Text] [Related]
3. Targeting CD52 as a novel therapeutic strategy in angioimmunoblastic T-cell lymphoma.
Dunleavy K; Wilson WH
Leuk Lymphoma; 2010 Sep; 51(9):1583-4. PubMed ID: 20795788
[No Abstract] [Full Text] [Related]
4. A male with angioimmunoblastic T-cell lymphoma and proliferative glomerulonephritis.
De Samblanx H; Verhoef G; Zachée P; Vandenberghe P
Ann Hematol; 2004 Jul; 83(7):455-9. PubMed ID: 15034757
[TBL] [Abstract][Full Text] [Related]
5. Angioimmunoblastic T-Cell Lymphoma with Polyarthritis Resembling Rheumatoid Arthritis.
Yachoui R; Farooq N; Amos JV; Shaw GR
Clin Med Res; 2016 Dec; 14(3-4):159-162. PubMed ID: 28188140
[TBL] [Abstract][Full Text] [Related]
6. Primary cerebral angioimmunoblastic T-cell lymphoma.
Lachenal F; Berger F; Cimarelli S; Formaglio M; Ghesquières H
J Clin Oncol; 2013 Feb; 31(5):e64-8. PubMed ID: 23295811
[No Abstract] [Full Text] [Related]
7. Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.
Broccoli A; Pellegrini C; Celli M; Argnani L; Agostinelli C; Pileri S; Zinzani PL
Clin Lymphoma Myeloma Leuk; 2014 Aug; 14(4):e119-22. PubMed ID: 24629851
[No Abstract] [Full Text] [Related]
8. [Angioimmunoblastic T-cell lymphoma with marked polyclonal plasmacytosis in peripheral blood and bone marrow mimicking plasma cell leukemia].
Mitsuhashi K; Shiseki M; Ishiyama M; Kondo T; Kazama H; Yasunami T; Okamura T; Yoshinaga K; Mori N; Teramura M; Masuda A; Motoji T
Rinsho Ketsueki; 2011 Jul; 52(7):563-9. PubMed ID: 21821991
[TBL] [Abstract][Full Text] [Related]
9. [Angioimmunoblastic T-cell lymphoma complicated by recurrent drug-induced agranulocytosis].
Inoue D; Kimura T; Shimoji S; Mori M; Nagai Y; Tabata S; Kurata M; Matsushita A; Nagai K; Maruoka H; Yamashita E; Takahashi T
Rinsho Ketsueki; 2009 Feb; 50(2):87-91. PubMed ID: 19265300
[TBL] [Abstract][Full Text] [Related]
10. Secondary Epstein-Barr virus associated lymphoproliferative disorder developing in a patient with angioimmunoblastic T cell lymphoma on vorinostat.
Smeltzer JP; Viswanatha DS; Habermann TM; Patnaik MM
Am J Hematol; 2012 Sep; 87(9):927-8. PubMed ID: 22718468
[TBL] [Abstract][Full Text] [Related]
11. The role of alemtuzumab in the management of T-cell malignancies.
Dearden C
Semin Oncol; 2006 Apr; 33(2 Suppl 5):S44-52. PubMed ID: 16720203
[TBL] [Abstract][Full Text] [Related]
12. Angioimmunoblastic T cell lymphoma associated with reversible myelofibrosis.
Matsui K; Adachi M; Tominaga T; Shinohara K; Kamei T
Intern Med; 2008; 47(21):1921-4. PubMed ID: 18981638
[TBL] [Abstract][Full Text] [Related]
13. [A case of angioimmunoblastic T-cell lymphoma with interstitial shadow which disappeared after injection of hydrocortisone].
Matsumiya H; Arai A; Nagai A
Nihon Kokyuki Gakkai Zasshi; 2006 Jul; 44(7):537-40. PubMed ID: 16886813
[TBL] [Abstract][Full Text] [Related]
14. [Reversible myelofibrosis in angioimmunoblastic lymphadenopathy].
Orth T; Treichel U; Mayet WJ; Störkel S; Meyer zum Büschenfelde KH
Dtsch Med Wochenschr; 1994 May; 119(19):694-8. PubMed ID: 8187622
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome associated with immunoblastic lymphadenopathy-like T-cell lymphoma: simultaneous clinical improvement with chemotherapy.
Anzai T; Hirose W; Nakane H; Kawagoe M; Kawai T; Watanabe K
Jpn J Clin Oncol; 1994 Apr; 24(2):106-10. PubMed ID: 8158857
[TBL] [Abstract][Full Text] [Related]
16. [Angioimmunoblastic T-cell lymphoma occurring four months after autologous peripheral blood stem cell transplantation with high-dose chemotherapy for follicular lymphoma].
Miyazaki K; Masuya M; Yamaguchi M; Isaka S; Nakase K; Kobayashi T; Nakamura S; Shiku H
Rinsho Ketsueki; 2005 Sep; 46(9):1065-70. PubMed ID: 16440766
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
[TBL] [Abstract][Full Text] [Related]
18. Treatment of angioimmunoblastic lymphadenopathy with dysproteinemia-type T-cell lymphoma with fludarabine.
Tsatalas C; Margaritis D; Pantelidou D; Spanudakis E; Kaloutsi V; Bourikas G
Acta Haematol; 2003; 109(2):110. PubMed ID: 12624498
[No Abstract] [Full Text] [Related]
19. [Immunoblastic lymphadenopathy-like T cell lymphoma associated with erythroid hypoplasia and thrombocytopenia].
Shirakawa C; Enomoto H; Tanaka H; Yonekawa S; Irimajiri K; Horiuchi A
Rinsho Ketsueki; 1996 Aug; 37(8):701-6. PubMed ID: 8827881
[TBL] [Abstract][Full Text] [Related]
20. Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies.
Alizadeh AA; Advani RH
Clin Adv Hematol Oncol; 2008 Dec; 6(12):899-909. PubMed ID: 19209140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
